Return to Search
NCD 210.3 Screening for Colorectal Cancer-Non-Invasive Biomarker Tests
This Change Request (CR) is to inform contractors that CMS has determined that effective June 8, 2026, non-invasive biomarker screening tests are appropriate colorectal cancer screening tests based on specific criteria.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: August 27, 2026
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.